BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29984229)

  • 1. CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling.
    Luo L; Liu Y; Chen D; Chen F; Lan HB; Xie C
    Biomed Res Int; 2018; 2018():3261436. PubMed ID: 29984229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Oxygen Species in COPD-Related Vascular Remodeling.
    Zuo L; Chuang CC; Clark AD; Garrison DE; Kuhlman JL; Sypert DC
    Adv Exp Med Biol; 2017; 967():399-411. PubMed ID: 29047102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trogocytosis of ligand-receptor complex and its intracellular transport in CD30 signalling.
    Nakashima M; Watanabe M; Uchimaru K; Horie R
    Biol Cell; 2018 May; 110(5):109-124. PubMed ID: 29431186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30L/CD30 protects against psoriasiform skin inflammation by suppressing Th17-related cytokine production by Vγ4
    Yue D; You Y; Zhang X; Wang B; Wang X; Qi R; Yang F; Meng X; Yoshikai Y; Wang Y; Sun X
    J Autoimmun; 2019 Jul; 101():70-85. PubMed ID: 31005389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema.
    Reimann S; Fink L; Wilhelm J; Hoffmann J; Bednorz M; Seimetz M; Dessureault I; Troesser R; Ghanim B; Klepetko W; Seeger W; Weissmann N; Kwapiszewska G
    Respir Res; 2015 Oct; 16():127. PubMed ID: 26483185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro.
    Hansen HP; Trad A; Dams M; Zigrino P; Moss M; Tator M; Schön G; Grenzi PC; Bachurski D; Aquino B; Dürkop H; Reiners KS; von Bergwelt-Baildon M; Hallek M; Grötzinger J; Engert A; Paes Leme AF; Pogge von Strandmann E
    Oncotarget; 2016 May; 7(21):30523-35. PubMed ID: 27105521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of Krüppel-like factor 5 in the remodeling of small airways and pulmonary vessels in chronic obstructive pulmonary disease.
    Abe K; Sugiura H; Hashimoto Y; Ichikawa T; Koarai A; Yamada M; Numakura T; Onodera K; Tanaka R; Sato K; Yanagisawa S; Okazaki T; Tamada T; Kikuchi T; Ichinose M
    Respir Res; 2016 Jan; 17():7. PubMed ID: 26792671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of capillary hypoxia-induced factor-alpha and pulmonary artery remodeling in chronic obstructive pulmonary disease].
    Li QF; Dai AG; Xu P
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):136-9. PubMed ID: 16624125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and expression of a soluble form of human CD30 ligand with functional activity.
    Powell IF; Li T; Jäck HM; Ellis TM
    J Leukoc Biol; 1998 Jun; 63(6):752-7. PubMed ID: 9620669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension.
    Hoffmann J; Wilhelm J; Marsh LM; Ghanim B; Klepetko W; Kovacs G; Olschewski H; Olschewski A; Kwapiszewska G
    Am J Respir Crit Care Med; 2014 Jul; 190(1):98-111. PubMed ID: 24918967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma.
    Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Nilsson G; Harvima IT
    Cancer Immunol Immunother; 2007 Sep; 56(9):1407-15. PubMed ID: 17268792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 ligand/CD30 interaction is involved in pathogenesis of inflammatory bowel disease.
    Somada S; Muta H; Nakamura K; Sun X; Honda K; Ihara E; Akiho H; Takayanagi R; Yoshikai Y; Podack ER; Tani K
    Dig Dis Sci; 2012 Aug; 57(8):2031-7. PubMed ID: 22451116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apoptosis versus proliferation activities of pulmonary artery smooth muscle cells in pulmonary arterial hypertension associated with chronic obstructive pulmonary disease].
    Yu WC; Guo CH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):657-61. PubMed ID: 18070547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remodelling.
    Yu WC; Cong JP; Mi LY
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):361-367. PubMed ID: 30133616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD.
    Kanazawa H; Asai K; Nomura S
    Respir Res; 2007 Mar; 8(1):22. PubMed ID: 17343763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role and mechanism of hydrogen sulfide in cigarette smoke induced chronic obstructive pulmonary disease related pulmonary vascular remodeling in rats].
    Li MX; Chen YH; Liao CC; Lin F; Bai Y; Mi WJ; Sun Y; Qi YF
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):137-142. PubMed ID: 28088960
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox.
    Nagaraj C; Tabeling C; Nagy BM; Jain PP; Marsh LM; Papp R; Pienn M; Witzenrath M; Ghanim B; Klepetko W; Weir EK; Heschl S; Kwapiszewska G; Olschewski A; Olschewski H
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28729471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD.
    Liu Y; Liu X; Lin G; Sun L; Li H; Xie C
    Heart Lung Circ; 2014 Sep; 23(9):875-82. PubMed ID: 24875532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease.
    Abd El-Fatah MF; Ghazy MA; Mostafa MS; El-Attar MM; Osman A
    Biochem Cell Biol; 2015 Dec; 93(6):541-7. PubMed ID: 26291981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases.
    Oflazoglu E; Grewal IS; Gerber H
    Adv Exp Med Biol; 2009; 647():174-85. PubMed ID: 19760074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.